DOCS.L
Dr. Martens plc [DOCS.L] Stock Forecast
Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
DOCS.L Stock Summary
Top DOCS.L Correlated Resources
DOCS.L
Top 10 Correlated ETFs
DOCS.L
Top 10 Correlated Stocks
DOCS.L
In the News
DOCS.L Financial details
Company Rating
-
Market Cap
1.33B
Income
-
Revenue
-
Book val./share
-
Cash/share
-
Dividend
0.06
Dividend %
4.32%
Employees
2.23K
Optionable
No
Shortable
Yes
Earnings
01 Jun 2023
P/E
7.47
Forward P/E
-
PEG
-
P/S
1.49
P/B
4.12
P/C
-
P/FCF
8.49
Quick Ratio
1.47
Current Ratio
2.86
Debt / Equity
1.83
LT Debt / Equity
1.18
-
-
EPS (TTM)
-
EPS next Y
-
EPS next Q
-
EPS this Y
400%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
21.11%
Revenue Q/Q
-
EPS Q/Q
-
-
-
-
-
SMA20
-14.52%
SMA50
-35.82%
SMA100
-45.03%
Inst Own
-
Inst Trans
-
ROA
21%
ROE
76%
ROC
0.32%
Gross Margin
64%
Oper. Margin
25%
Profit Margin
20%
Payout
7%
Shs Outstand
1B
Shs Float
548.86M
-
-
-
-
Target Price
-
52W Range
128.3-295.212
52W High
-54.81%
52W Low
+4.14%
RSI
35.48
Rel Volume
0.49
Avg Volume
3.94M
Volume
1.93M
Perf Week
3.9%
Perf Month
-13.16%
Perf Quarter
-42.19%
Perf Half Y
-50.96%
-
-
-
-
Beta
0.029898
-
-
Volatility
1.2%, 10.37%
Prev Close
-1.04%
Price
133.3
Change
2.54%
DOCS.L Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-03-31
| Metric | History | 2018-03-31 | 2019-03-31 | 2020-03-31 | 2021-03-31 | 2022-03-31 |
|---|---|---|---|---|---|---|
| Revenue per share | 0.35 | 0.45 | 0.67 | 0.77 | 0.91 | |
| Net income per share | -0.01 | 0.02 | 0.07 | 0.04 | 0.18 | |
| Operating cash flow per share | 0.05 | 0.06 | 0.12 | 0.16 | 0.18 | |
| Free cash flow per share | 0.03 | 0.04 | 0.1 | 0.14 | 0.16 | |
| Cash per share | 0.09 | 0.06 | 0.12 | 0.11 | 0.23 | |
| Book value per share | -0.03 | -0.01 | 0.07 | 0.15 | 0.33 | |
| Tangible book value per share | -0.28 | -0.26 | -0.19 | -0.11 | 0.07 | |
| Share holders equity per share | -0.03 | -0.01 | 0.07 | 0.15 | 0.33 | |
| Interest debt per share | 0.12 | 0.11 | 0.22 | 0.41 | 0.41 | |
| Market cap | 4.5B | 4.5B | 4.5B | 4.53B | 2.39B | |
| Enterprise value | 4.49B | 4.52B | 4.57B | 4.78B | 2.55B | |
| P/E ratio | -789.47 | 261.63 | 60.16 | 126.95 | 13.18 | |
| Price to sales ratio | 12.91 | 9.9 | 6.69 | 5.86 | 2.63 | |
| POCF ratio | 97.83 | 80.36 | 37.07 | 28.29 | 12.95 | |
| PFCF ratio | 152.03 | 115.68 | 45.23 | 32.01 | 14.98 | |
| P/B Ratio | -153.06 | -535.71 | 63.83 | 30.07 | 7.28 | |
| PTB ratio | -153.06 | -535.71 | 63.83 | 30.07 | 7.28 | |
| EV to sales | 12.88 | 9.94 | 6.79 | 6.19 | 2.81 | |
| Enterprise value over EBITDA | 97.62 | 58.04 | 26.67 | 33.09 | 9.64 | |
| EV to operating cash flow | 97.62 | 80.64 | 37.61 | 29.87 | 13.85 | |
| EV to free cash flow | 151.7 | 116.09 | 45.88 | 33.79 | 16.02 | |
| Earnings yield | 0 | 0 | 0.02 | 0.01 | 0.08 | |
| Free cash flow yield | 0.01 | 0.01 | 0.02 | 0.03 | 0.07 | |
| Debt to equity | -16.16 | -54.6 | 8.31 | 3.33 | 1.62 | |
| Debt to assets | 1.07 | 1.02 | 0.89 | 0.77 | 0.62 | |
| Net debt to EBITDA | -0.21 | 0.2 | 0.38 | 1.75 | 0.63 | |
| Current ratio | 3.04 | 2.57 | 2.12 | 1.8 | 2.86 | |
| Interest coverage | 1.04 | 1.78 | 3.5 | 2.91 | 16.38 | |
| Income quality | -8.07 | 3.26 | 1.62 | 4.49 | 1.02 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0.01 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0.07 | |
| Sales general and administrative to revenue | 0.42 | 0.42 | 0.39 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.56 | 0.56 | 0.39 | 0.4 | 0.31 | |
| Capex to operating cash flow | -0.36 | -0.31 | -0.18 | -0.12 | -0.14 | |
| Capex to revenue | -0.05 | -0.04 | -0.03 | -0.02 | -0.03 | |
| Capex to depreciation | -2.52 | -1.61 | -0.74 | -0.53 | -0.68 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0.01 | 0.01 | |
| Graham number | 0.06 | 0.06 | 0.34 | 0.35 | 1.16 | |
| ROIC | -1.29 | 0.13 | 0.27 | 0.15 | 0.55 | |
| Return on tangible assets | -0.03 | 0.09 | 0.19 | 0.09 | 0.3 | |
| Graham Net | -0.37 | -0.37 | -0.42 | -0.34 | -0.24 | |
| Working capital | 113.7M | 101M | 146.5M | 122.5M | 288.6M | |
| Tangible asset value | -277.9M | -260.2M | -186.7M | -110.1M | 66.1M | |
| Net current asset value | -305.9M | -293.1M | -308.8M | -227.3M | -87.3M | |
| Invested capital | -2.61 | -8.85 | 2.59 | 2.43 | 1.2 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 0 | 19.8M | 26.7M | 43M | 52.5M | |
| Average inventory | 0 | 46.85M | 71.95M | 95.75M | 112.25M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 44 | 37.67 | 45.04 | 63.47 | 58.05 | |
| Days of inventory on hand | 89.34 | 101.51 | 121.35 | 122.47 | 136.25 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 8.3 | 9.69 | 8.1 | 5.75 | 6.29 | |
| Inventory turnover | 4.09 | 3.6 | 3.01 | 2.98 | 2.68 | |
| ROE | 0.19 | -2.05 | 1.06 | 0.24 | 0.55 | |
| Capex per share | -0.02 | -0.02 | -0.02 | -0.02 | -0.03 |
Quarterly Fundamentals Overview
Last date of statement is 2022-09-30 for Q2
| Metric | History | 2020-09-30 | 2021-03-31 | 2021-09-30 | 2022-03-31 | 2022-09-30 |
|---|---|---|---|---|---|---|
| Revenue per share | 0 | 0 | 0 | 0 | 0 | |
| Net income per share | 0 | 0 | 0 | 0 | 0 | |
| Operating cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow per share | 0 | 0 | 0 | 0 | 0 | |
| Cash per share | 0 | 0 | 0 | 0 | 0 | |
| Book value per share | 0 | 0 | 0 | 0 | 0 | |
| Tangible book value per share | 0 | 0 | 0 | 0 | 0 | |
| Share holders equity per share | 0 | 0 | 0 | 0 | 0 | |
| Interest debt per share | 0 | 0 | 0 | 0 | 0 | |
| Market cap | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value | 27.9M | 252.8M | 270.9M | 165.8M | 302.7M | |
| P/E ratio | 0 | 0 | 0 | 0 | 0 | |
| Price to sales ratio | 0 | 0 | 0 | 0 | 0 | |
| POCF ratio | 0 | 0 | 0 | 0 | 0 | |
| PFCF ratio | 0 | 0 | 0 | 0 | 0 | |
| P/B Ratio | 0 | 0 | 0 | 0 | 0 | |
| PTB ratio | 0 | 0 | 0 | 0 | 0 | |
| EV to sales | 0 | 0 | 0 | 0 | 0 | |
| Enterprise value over EBITDA | 0 | 0 | 0 | 0 | 0 | |
| EV to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| EV to free cash flow | 0 | 0 | 0 | 0 | 0 | |
| Earnings yield | 0 | 0 | 0 | 0 | 0 | |
| Free cash flow yield | 0 | 0 | 0 | 0 | 0 | |
| Debt to equity | 6.48 | 3.33 | 2.49 | 1.62 | 1.83 | |
| Debt to assets | 0.87 | 0.77 | 0.71 | 0.62 | 0.65 | |
| Net debt to EBITDA | 0 | 0 | 0 | 0 | 0 | |
| Current ratio | 2.03 | 1.8 | 2.24 | 2.86 | 2.39 | |
| Interest coverage | 0 | 0 | 0 | 0 | 0 | |
| Income quality | 0 | 0 | 0 | 0 | 0 | |
| Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
| Payout ratio | 0 | 0 | 0 | 0 | 0 | |
| Sales general and administrative to revenue | 0 | 0 | 0 | 0 | 0 | |
| Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
| Intangibles to total assets | 0.35 | 0.4 | 0.37 | 0.31 | 0.27 | |
| Capex to operating cash flow | 0 | 0 | 0 | 0 | 0 | |
| Capex to revenue | 0 | 0 | 0 | 0 | 0 | |
| Capex to depreciation | 0 | 0 | 0 | 0 | 0 | |
| Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
| Graham number | 0 | 0 | 0 | 0 | 0 | |
| ROIC | 0 | 0 | 0 | 0 | 0 | |
| Return on tangible assets | 0 | 0 | 0 | 0 | 0 | |
| Graham Net | 0 | 0 | 0 | 0 | 0 | |
| Working capital | 189.1M | 122.5M | 173.8M | 288.6M | 304.7M | |
| Tangible asset value | -159.4M | -110.1M | -57.7M | 66.1M | 81.4M | |
| Net current asset value | -277.8M | -227.3M | -192M | -87.3M | -111.2M | |
| Invested capital | 1.74 | 2.43 | 1.89 | 1.2 | 1.26 | |
| Average receivables | 0 | 0 | 0 | 0 | 0 | |
| Average payables | 58.45M | 68.05M | 49.3M | 49.2M | 79.05M | |
| Average inventory | 109M | 114.75M | 110.65M | 121.4M | 192.2M | |
| Days sales outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days payables outstanding | 0 | 0 | 0 | 0 | 0 | |
| Days of inventory on hand | 0 | 0 | 0 | 0 | 0 | |
| Receivables turnover | 0 | 0 | 0 | 0 | 0 | |
| Payables turnover | 0 | 0 | 0 | 0 | 0 | |
| Inventory turnover | 0 | 0 | 0 | 0 | 0 | |
| ROE | 0 | 0 | 0 | 0 | 0 | |
| Capex per share | 0 | 0 | 0 | 0 | 0 |
DOCS.L Frequently Asked Questions
What is Dr. Martens plc stock symbol ?
Dr. Martens plc is a GB stock and trading under the symbol DOCS.L
What is Dr. Martens plc stock quote today ?
Dr. Martens plc stock price is $133.3 today.
Is Dr. Martens plc stock public?
Yes, Dr. Martens plc is a publicly traded company.
Company Profile
- Volume Average 3.94M
- Market Capitalization 1.33B
- Employee 2.23K
- CEO Mr. Kenneth Wilson
- Headquarters London,GB
- IPO Date 2021-01-29
-
Website
https://www.drmartensplc.com 
Dr. Martens plc designs, develops, procures, markets, sells, and distributes footwear in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. Its product segments include originals, fusion, kids, and casual, as well as accessories. The company offers its products under the Dr. Martens brand name. Dr. Martens plc was founded in 1945 and is based in London, the United Kingdom.
